You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 8, August 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cancer and Scleroderma

Scott C. Duncan, MD; R. K. Winkelmann, MD, PhD

Arch Dermatol. 1979;115(8):950-955.


Abstract

Of 2,141 patients with scleroderma who were seen at the Mayo Clinic, Rochester, Minn, between 1959 and 1975, 78 had 87 internal malignancies. The relative frequency of the types of cancers was similar to that for the general population. The increased numbers of patients with breast and uterine carcinomas were consistent with the female preponderance in scleroderma. Contrary to previous reports, carcinoma of the lung was not the most frequent malignancy associated with scleroderma. The lymphoma-leukemia malignancies were second only to breast carcinoma in frequency, comprising about 17% of the malignancies. Both conditions developed within a three-year period in 68% (45/66) of our patients affected with systemic scleroderma, and this subgroup comprised a high mortality group. This study is not an epidemiologic one in the strictest sense, but it is a review of the experience of the Mayo Clinic with patients who have had both scleroderma and an internal malignancy.

(Arch Dermatol 115:950-955, 1979)



Author Affiliations

From the Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication Feb 26, 1979.

Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Duncan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Survival and causes of death in 366 Hungarian patients with systemic sclerosis
Czirjak et al.
Ann Rheum Dis 2008;67:59-63.
ABSTRACT | FULL TEXT  

Risk of cancer in patients with scleroderma
Pearson and Silman
Ann Rheum Dis 2003;62:697-699.
FULL TEXT  

Risk of cancer in patients with scleroderma: a population based cohort study
Hill et al.
Ann Rheum Dis 2003;62:728-731.
ABSTRACT | FULL TEXT  

Primary malignant lymphoma of superior vena cava
Nomori et al.
Ann. Thorac. Surg. 1998;66:1423-1424.
ABSTRACT | FULL TEXT  

Cutaneous and Subcutaneous Inflammatory Sclerosis Syndromes
Doyle et al.
Arch Dermatol 1982;118:886-890.
ABSTRACT  

Palmar Fasciitis and Polyarthritis Associated with Ovarian Carcinoma
MEDSGER et al.
ANN INTERN MED 1982;96:424-431.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.